Abstract:Background Nasopharyngeal carcinoma (NPC) is a distinct subtype of head and neck cancer which is prevalent in south of China and southeastern of Asia. Consistent activation of interferon (IFN) signaling, and impairment of T cell mediated antitumor immunity is frequent in NPC. Forkhead box A1 (FOXA1) is one of the earliest discovered pioneer factors, which can open up compact chromatin structures to facilitate the binding of other proteins to chromatin.Methods By using RNA sequencing, it was discovered that FOXA1 suppresses the activation of the interferon signaling pathway and the expression of the related interferon-responsive genes in NPC cells. The effect of FOXA1 on programmed death-ligand 1 (PD-L1) expression in C666-1 and HK1 cells under conditions with or without IFN-γ was detected through quantitative PCR (qPCR), western blot, and flow cytometry. After co-culturing T cells with IFN-γ-treated NPC cells in vitro, apoptosis of CD8+ T cells and the expression of cytotoxic cytokines were assessed by flow cytometry. The cytotoxic effects of T cells on tumor cells in nude mice were measured by tumorigenesis in nude mice and adoptive T cell therapy. The effects of IFN-γ on the expression and nuclear localization of STAT1, as well as the colocalization of FOXA1 with STAT1 were detected by immunofluorescence, qPCR, western blot, and co-immunoprecipitation experiments.Results In this study, we reported that loss of FOXA1, a pioneer factor downregulated in NPC, results in activation of IFN signaling in NPC cells. Repression of FOXA1 facilitates IFN-γ induced PD-L1 expression, whereas overexpression of FOXA1 exerts the opposite effect. Mechanistically, FOXA1 interacts with STAT1 and inhibits IRF1 expression and binding to PD-L1 promoter on IFN-γ treatment. Co-culture with FOXA1-silenced NPC cells promotes apoptosis of in vitro activated tumor-specific CD8+T cells and reduces the expression of cytotoxic effector molecules. Furthermore, overexpression of FOXA1 increases the therapeutic efficacy of PD-L1 antibody (atezolizumab) against NPC in nude mice receiving adoptive T-cell therapy.Conclusions We demonstrated that FOXA1 prevents tumor immune evasion by inhibiting IFN-γ induced PD-L1 expression in NPC cells. Our research findings provide new insights into the immunotherapeutic biomarkers and targets for NPC, which is important for the clinical application of programmed cell death protein-1/PD-L1 antibodies in NPC.

FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells Through Repressing Mir-100-5p and Mir-125B-5p.

The Developmental Transcription Factor IRF6 Attenuates ABCG2 Gene Expression and Distinctively Reverses Stemness Phenotype in Nasopharyngeal Carcinoma.

FOXA1 Reprograms the TGF-β-stimulated Transcriptional Program from a Metastasis Promoter to a Tumor Suppressor in Nasopharyngeal Carcinoma.

FOXA1 Enhances Antitumor Immunity Via Repressing Interferon-Induced PD-L1 Expression in Nasopharyngeal Carcinoma

MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma

miR-29a/b Enhances Cell Migration and Invasion in Nasopharyngeal Carcinoma Progression by Regulating SPARC and COL3A1 Gene Expression

LncRNA HOXC-AS1 Promotes Nasopharyngeal Carcinoma (NPC) Progression by Sponging Mir-4651 and Subsequently Upregulating FOXO6.

MicroRNA-18a Promotes Cancer Progression Through SMG1 Suppression and Mtor Pathway Activation in Nasopharyngeal Carcinoma.

MiR-99a Suppresses Cell Invasion and Metastasis in Nasopharyngeal Carcinoma Through Targeting HOXA1

Mir-9 Targets CXCR4 and Functions As a Potential Tumor Suppressor in Nasopharyngeal Carcinoma.

Long non-coding RNA FOXP4-AS1 acts as an adverse prognostic factor and regulates proliferation and apoptosis in nasopharyngeal carcinoma

miRNA‐22‐3p inhibits cell viability and metastasis of nasopharyngeal carcinoma by targeting FOXP1

MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1 alpha in nasopharyngeal carcinoma

miR-1254 induced by NESG1 inactivates HDGF/DDX5-stimulated nuclear translocation of β-catenin and suppresses NPC metastasis

FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma

MicroRNA-19b-3p Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting TNFAIP3/NF-κB Axis

Microrna-613 Exerts Anti-Angiogenic Effect on Nasopharyngeal Carcinoma Cells Through Inactivating the AKT Signaling Pathway by Down-Regulating FN1

A direct negative feedback loop of miR-4721/FOXA1/Nanog promotes nasopharyngeal cell stem cell enrichment and metastasis

LncRNA FOXP4-AS1 Silencing Inhibits Metastasis and Epithelial–mesenchymal Transition in Nasopharyngeal Carcinoma Via Mir-136-5p/mapk1

Long Non-Coding RNA FOXD2-AS1 Aggravates Nasopharyngeal Carcinoma Carcinogenesis by Modulating Mir-363-5p/s100a1 Pathway.

MiR-138 Suppressed Nasopharyngeal Carcinoma Growth and Tumorigenesis by Targeting the CCND1 Oncogene